世界の増殖性糖尿病性網膜症市場2019

• 英文タイトル：Global Proliferative Diabetic Retinopathy Sales Market Report 2019

• レポートコード：QYR9N3782
• 出版社/出版日：QYResearch / 2019年6月13日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートでは、増殖性糖尿病性網膜症の世界市場について調査・分析し、増殖性糖尿病性網膜症のメーカー別販売量、市場シェア分析、種類別販売分析（抗VEGF剤、コルチコステロイド）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・増殖性糖尿病性網膜症市場概要
・増殖性糖尿病性網膜症のメーカー別販売量・メーカー別シェア
・増殖性糖尿病性網膜症の種類別販売量（抗VEGF剤、コルチコステロイド）
・増殖性糖尿病性網膜症の用途別販売量（病院、診療所、その他）
・増殖性糖尿病性網膜症の地域別販売量・市場シェア
・増殖性糖尿病性網膜症の米国市場規模（2014年-2019年）
・増殖性糖尿病性網膜症のヨーロッパ市場規模（2014年-2019年）
・増殖性糖尿病性網膜症の中国市場規模（2014年-2019年）
・増殖性糖尿病性網膜症の日本市場規模（2014年-2019年）
・増殖性糖尿病性網膜症の東南アジア市場規模（2014年-2019年）
・増殖性糖尿病性網膜症のインド市場規模（2014年-2019年）
・増殖性糖尿病性網膜症メーカー分析（企業概要、製品概要、販売量、売上、価格等）
・増殖性糖尿病性網膜症のコスト分析
・増殖性糖尿病性網膜症販売チャネル、流通業者、顧客
・増殖性糖尿病性網膜症の世界市場動向・機会・成長要因・課題
・増殖性糖尿病性網膜症の種類別世界市場予測（抗VEGF剤、コルチコステロイド）
・増殖性糖尿病性網膜症の用途別世界市場予測（病院、診療所、その他）
・増殖性糖尿病性網膜症の米国市場予測（2019年-2025年）
・増殖性糖尿病性網膜症のヨーロッパ市場予測（2019年-2025年）
・増殖性糖尿病性網膜症の中国市場予測（2019年-2025年）
・増殖性糖尿病性網膜症の日本市場予測（2019年-2025年）
・増殖性糖尿病性網膜症の東南アジア市場予測（2019年-2025年）
・増殖性糖尿病性網膜症のインド市場予測（2019年-2025年）
...

The global Proliferative Diabetic Retinopathy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Proliferative Diabetic Retinopathy market status and forecast, categorizes the global Proliferative Diabetic Retinopathy market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Intas Pharmaceuticals
Santen Pharmaceutical
Valeant Pharmaceuticals International
Allergan Plc
Regeneron Pharmaceuticals
Merck KGaA
Cipla
Genentech, Inc. (Roche Holdings)
Novartis
Pfizer

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Anti-VEGF Agents
Corticosteroids

Segment by Application
Hospitals
Clinics
Others

レポート目次

Table of Contents

Global Proliferative Diabetic Retinopathy Sales Market Report 2019
1 Proliferative Diabetic Retinopathy Market Overview
1.1 Proliferative Diabetic RetinopathyProduct Overview
1.2 Proliferative Diabetic Retinopathy Segment by Type
1.2.1 Global Proliferative Diabetic Retinopathy Sales Comparison by Types (2014-2025)
1.2.2 Anti-VEGF Agents
1.2.3 Corticosteroids
1.3 Proliferative Diabetic Retinopathy Segment by Application
1.3.1 Global Proliferative Diabetic Retinopathy Sales Comparison by Application (2014-2025)
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Proliferative Diabetic Retinopathy Market by Region
1.4.1 Global Proliferative Diabetic Retinopathy Revenue Comparison by Region (2014-2025)
1.4.2 United States Proliferative Diabetic Retinopathy Status and Prospect (2014-2025)
1.4.3 Europe Proliferative Diabetic Retinopathy Status and Prospect (2014-2025)
1.4.4 China Proliferative Diabetic Retinopathy Status and Prospect (2014-2025)
1.4.5 Japan Proliferative Diabetic Retinopathy Status and Prospect (2014-2025)
1.4.6 Southeast Asia Proliferative Diabetic Retinopathy Status and Prospect (2014-2025)
1.4.7 India Proliferative Diabetic Retinopathy Status and Prospect (2014-2025)
1.5 Global Proliferative Diabetic Retinopathy Sales and Revenue (2014-2025)
1.5.1 Global Proliferative Diabetic Retinopathy Sales and Growth Rate (2014-2025)
1.5.2 Global Proliferative Diabetic Retinopathy Revenue and Growth Rate (2014-2025)

2 Proliferative Diabetic Retinopathy by Company, Region, Type and Application
2.1 Global Proliferative Diabetic Retinopathy Market Competition by Companies
2.1.1 Global Proliferative Diabetic Retinopathy Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Proliferative Diabetic Retinopathy Revenue Market Share by Company (2014-2019)
2.2 Global Proliferative Diabetic Retinopathy Sales and Revenue by Region
2.2.1 Global Proliferative Diabetic Retinopathy Sales Market Share by Region (2014-2019)
2.2.2 Global Proliferative Diabetic Retinopathy Revenue Market Share by Region (2014-2019)
2.3 Global Proliferative Diabetic Retinopathy Sales and Revenue by Type
2.3.1 Global Proliferative Diabetic Retinopathy Sales Market Share by Type (2014-2019)
2.3.2 Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2014-2019)
2.4 Global Proliferative Diabetic Retinopathy Sales by Application

3 United States Proliferative Diabetic Retinopathy Sales, Revenue and Price
3.1 United States Proliferative Diabetic Retinopathy Sales and Revenue (2014-2019)
3.1.1 United States Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
3.1.2 United States Proliferative Diabetic Retinopathy Revenue Growth Rate (2014-2019)
3.1.3 United States Proliferative Diabetic Retinopathy Price Trend (2014-2019)
3.2 United States Proliferative Diabetic Retinopathy Sales Market Share by Company
3.3 United States Proliferative Diabetic Retinopathy Sales Market Share by Type
3.4 United States Proliferative Diabetic Retinopathy Sales Market Share by Application

4 Europe Proliferative Diabetic Retinopathy Sales, Revenue and Price
4.1 Europe Proliferative Diabetic Retinopathy Sales and Value (2014-2019)
4.1.1 Europe Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
4.1.2 Europe Proliferative Diabetic Retinopathy Revenue Growth Rate (2014-2019)
4.1.3 Europe Proliferative Diabetic Retinopathy Price Trend (2014-2019)
4.2 Europe Proliferative Diabetic Retinopathy Sales Market Share by Company
4.3 Europe Proliferative Diabetic Retinopathy Sales Market Share by Type
4.4 Europe Proliferative Diabetic Retinopathy Sales Market Share by Application

5 China Proliferative Diabetic Retinopathy Sales, Revenue and Price
5.1 China Proliferative Diabetic Retinopathy Sales and Revenue (2014-2019)
5.1.1 China Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
5.1.2 China Proliferative Diabetic Retinopathy Revenue Growth Rate (2014-2019)
5.1.3 China Proliferative Diabetic Retinopathy Price Trend (2014-2019)
5.2 China Proliferative Diabetic Retinopathy Sales Market Share by Company
5.3 China Proliferative Diabetic Retinopathy Sales Market Share by Type
5.4 China Proliferative Diabetic Retinopathy Sales Market Share by Application

6 Japan Proliferative Diabetic Retinopathy Sales, Revenue and Price
6.1 Japan Proliferative Diabetic Retinopathy Sales and Value (2014-2019)
6.1.1 Japan Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
6.1.2 Japan Proliferative Diabetic Retinopathy Revenue Growth Rate (2014-2019)
6.1.3 Japan Proliferative Diabetic Retinopathy Price Trend (2014-2019)
6.2 Japan Proliferative Diabetic Retinopathy Sales Market Share by Company
6.3 Japan Proliferative Diabetic Retinopathy Sales Market Share by Type
6.4 Japan Proliferative Diabetic Retinopathy Sales Market Share by Application

7 Southeast Asia Proliferative Diabetic Retinopathy Sales, Revenue and Price
7.1 Southeast Asia Proliferative Diabetic Retinopathy Sales and Value (2014-2019)
7.1.1 Southeast Asia Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Proliferative Diabetic Retinopathy Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Proliferative Diabetic Retinopathy Price Trend (2014-2019)
7.2 Southeast Asia Proliferative Diabetic Retinopathy Sales Market Share by Company
7.3 Southeast Asia Proliferative Diabetic Retinopathy Sales Market Share by Type
7.4 Southeast Asia Proliferative Diabetic Retinopathy Sales Market Share by Application

8 India Proliferative Diabetic Retinopathy Sales, Revenue and Price
8.1 India Proliferative Diabetic Retinopathy Sales and Value (2014-2019)
8.1.1 India Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
8.1.2 India Proliferative Diabetic Retinopathy Revenue Growth Rate (2014-2019)
8.1.3 India Proliferative Diabetic Retinopathy Price Trend (2014-2019)
8.2 India Proliferative Diabetic Retinopathy Sales Market Share by Company
8.3 India Proliferative Diabetic Retinopathy Sales Market Share by Type
8.4 India Proliferative Diabetic Retinopathy Sales Market Share by Application

9 Company Profiles and Key Figures in Proliferative Diabetic Retinopathy Business
9.1 Intas Pharmaceuticals
9.1.1 Intas Pharmaceuticals Proliferative Diabetic Retinopathy Production Sites and Area Served
9.1.2 Proliferative Diabetic Retinopathy Specification and Application
9.1.3 Intas Pharmaceuticals Proliferative Diabetic Retinopathy Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Santen Pharmaceutical
9.2.1 Santen Pharmaceutical Proliferative Diabetic Retinopathy Production Sites and Area Served
9.2.2 Proliferative Diabetic Retinopathy Specification and Application
9.2.3 Santen Pharmaceutical Proliferative Diabetic Retinopathy Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Valeant Pharmaceuticals International
9.3.1 Valeant Pharmaceuticals International Proliferative Diabetic Retinopathy Production Sites and Area Served
9.3.2 Proliferative Diabetic Retinopathy Specification and Application
9.3.3 Valeant Pharmaceuticals International Proliferative Diabetic Retinopathy Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Allergan Plc
9.4.1 Allergan Plc Proliferative Diabetic Retinopathy Production Sites and Area Served
9.4.2 Proliferative Diabetic Retinopathy Specification and Application
9.4.3 Allergan Plc Proliferative Diabetic Retinopathy Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Regeneron Pharmaceuticals
9.5.1 Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Production Sites and Area Served
9.5.2 Proliferative Diabetic Retinopathy Specification and Application
9.5.3 Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Merck KGaA
9.6.1 Merck KGaA Proliferative Diabetic Retinopathy Production Sites and Area Served
9.6.2 Proliferative Diabetic Retinopathy Specification and Application
9.6.3 Merck KGaA Proliferative Diabetic Retinopathy Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Cipla
9.7.1 Cipla Production Sites and Area Served
9.7.2 Proliferative Diabetic Retinopathy Specification and Application
9.7.3 Cipla Proliferative Diabetic Retinopathy Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 Genentech, Inc. (Roche Holdings)
9.8.1 Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Production Sites and Area Served
9.8.2 Proliferative Diabetic Retinopathy Specification and Application
9.8.3 Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 Novartis
9.9.1 Novartis Proliferative Diabetic Retinopathy Production Sites and Area Served
9.9.2 Proliferative Diabetic Retinopathy Specification and Application
9.9.3 Novartis Proliferative Diabetic Retinopathy Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served
9.10 Pfizer
9.10.1 Pfizer Proliferative Diabetic Retinopathy Production Sites and Area Served
9.10.2 Proliferative Diabetic Retinopathy Specification and Application
9.10.3 Pfizer Proliferative Diabetic Retinopathy Sales, Revenue, Price and Gross Margin (2014-2019)
9.10.4 Main Business and Markets Served

10 Proliferative Diabetic Retinopathy Maufacturing Cost Analysis
10.1 Proliferative Diabetic Retinopathy Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Proliferative Diabetic Retinopathy
10.4 Proliferative Diabetic Retinopathy Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Proliferative Diabetic Retinopathy Distributors List
11.3 Proliferative Diabetic Retinopathy Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Proliferative Diabetic Retinopathy Market Forecast
13.1 Global Proliferative Diabetic Retinopathy Sales, Revenue and Price Forecast
13.1.1 Global Proliferative Diabetic Retinopathy Sales Growth Forecast (2019-2025)
13.1.2 Global Proliferative Diabetic Retinopathy Revenue Growth Forecast (2019-2025)
13.1.3 Global Proliferative Diabetic Retinopathy Price Trend Forecast (2019-2025)
13.2 Global Proliferative Diabetic Retinopathy Forecast by Region
13.2.1 Global Proliferative Diabetic Retinopathy Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Proliferative Diabetic Retinopathy Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Proliferative Diabetic Retinopathy Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Proliferative Diabetic Retinopathy Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Proliferative Diabetic Retinopathy Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Proliferative Diabetic Retinopathy Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Proliferative Diabetic Retinopathy Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Proliferative Diabetic Retinopathy Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Proliferative Diabetic Retinopathy Forecast by Type
13.3.1 Global Proliferative Diabetic Retinopathy Sales Forecast by Type (2019-2025)
13.3.2 Global Proliferative Diabetic Retinopathy Revenue Forecast by Type (2019-2025)
13.3.3 Global Proliferative Diabetic Retinopathy Price Forecast by Type (2019-2025)
13.4 Global Proliferative Diabetic Retinopathy Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Proliferative Diabetic Retinopathy Sales (K Units) and Value (Revenue: Million US$)
Market Breakdown by Type: Proliferative Diabetic Retinopathy Sales (K Units) and Revenue (Million US$)
Market Breakdown by Application: Proliferative Diabetic Retinopathy Sales (Jan)
Figure Proliferative Diabetic Retinopathy Product Picture
Table Global Proliferative Diabetic Retinopathy Sales (K Units) Growth Rate by Types (2014-2025)
Figure Global Proliferative Diabetic Retinopathy Sales Market Share by Types in 2018
Figure Anti-VEGF Agents Product Picture
Figure Corticosteroids Product Picture
Table Global Proliferative Diabetic Retinopathy Sales (K Units) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Proliferative Diabetic Retinopathy by Application in 2018
Figure Hospitals Examples
Figure Clinics Examples
Figure Others Examples
Table Global Market Proliferative Diabetic Retinopathy Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Proliferative Diabetic Retinopathy Sales (K Units) Growth Rate (2014-2025)
Figure Global Proliferative Diabetic Retinopathy Revenue (Million USD) Growth Rate (2014-2025)
Table Global Proliferative Diabetic Retinopathy Sales (K Units) of Key Companies (2014-2019)
Figure Global Proliferative Diabetic Retinopathy Sales by Company in 2018
Table Global Proliferative Diabetic Retinopathy Sales Share by Company (2014-2019)
Figure Global Proliferative Diabetic Retinopathy Sales Share by Company in 2018
Table Global Proliferative Diabetic Retinopathy Revenue (Million USD) by Company (2014-2019)
Figure Global Proliferative Diabetic Retinopathy Revenue (Million USD) by Company in 2018
Table Global Proliferative Diabetic Retinopathy Revenue Share by Company (2014-2019)
Figure Global Proliferative Diabetic Retinopathy Revenue Share by Company in 2018
Table Global Proliferative Diabetic Retinopathy Sales (K Units) Market Share by Region (2014-2019)
Table Global Proliferative Diabetic Retinopathy Sales Share by Region (2014-2019)
Figure Global Proliferative Diabetic Retinopathy Sales Share by Region in 2018
Table Global Proliferative Diabetic Retinopathy Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Proliferative Diabetic Retinopathy Revenue Share by Region (2014-2019)
Figure Global Proliferative Diabetic Retinopathy Revenue Market Share by Region In 2018
Table Global Proliferative Diabetic Retinopathy Sales (K Units) by Type (2014-2019)
Table Global Proliferative Diabetic Retinopathy Sales Share by Type (2014-2019)
Figure Global Proliferative Diabetic Retinopathy Sales Growth Rate by Type in 2018
Table Global Proliferative Diabetic Retinopathy Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Proliferative Diabetic Retinopathy Revenue Share by Type (2014-2019)
Figure Global Proliferative Diabetic Retinopathy Revenue Growth Rate by Type in 2018
Table Global Proliferative Diabetic Retinopathy Sales Market Share by Application (2014-2019)
Table Global Proliferative Diabetic Retinopathy Sales Share by Application (2014-2019)
Figure Global Proliferative Diabetic Retinopathy Sales Market Share by Application in 2018
Figure United States Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate (2014-2019)
Figure United States Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Proliferative Diabetic Retinopathy Price (USD/Unit) Trend (2014-2019)
Table United States Proliferative Diabetic Retinopathy Sales (K Units) by Company (2014-2019)
Table United States Proliferative Diabetic Retinopathy Sales Market Share by Company (2014-2019)
Figure United States Proliferative Diabetic Retinopathy Sales Market Share by Company in 2018
Table United States Proliferative Diabetic Retinopathy Sales (K Units) by Type (2014-2019)
Table United States Proliferative Diabetic Retinopathy Sales Market Share by Type (2014-2019)
Figure United States Proliferative Diabetic Retinopathy Sales Market Share by Type in 2018
Table United States Proliferative Diabetic Retinopathy Sales (K Units) by Application (2014-2019)
Table United States Proliferative Diabetic Retinopathy Sales Market Share by Application (2014-2019)
Figure United States Proliferative Diabetic Retinopathy Sales Market Share by Application in 2018
Figure Europe Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate (2014-2019)
Figure Europe Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Proliferative Diabetic Retinopathy Price (USD/Unit) Trend (2014-2019)
Table Europe Proliferative Diabetic Retinopathy Sales (K Units) by Company (2014-2019)
Table Europe Proliferative Diabetic Retinopathy Sales Market Share by Company (2014-2019)
Figure Europe Proliferative Diabetic Retinopathy Sales Market Share by Company in 2018
Table Europe Proliferative Diabetic Retinopathy Sales (K Units) by Type (2014-2019)
Table Europe Proliferative Diabetic Retinopathy Sales Market Share by Type (2014-2019)
Figure Europe Proliferative Diabetic Retinopathy Sales Market Share by Type in 2018
Table Europe Proliferative Diabetic Retinopathy Sales (K Units) by Application (2014-2019)
Table Europe Proliferative Diabetic Retinopathy Sales Market Share by Application (2014-2019)
Figure Europe Proliferative Diabetic Retinopathy Sales Market Share by Application in 2018
Figure China Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate (2014-2019)
Figure China Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Proliferative Diabetic Retinopathy Price (USD/Unit) Trend (2014-2019)
Table China Proliferative Diabetic Retinopathy Sales (K Units) by Company (2014-2019)
Table China Proliferative Diabetic Retinopathy Sales Market Share by Company (2014-2019)
Figure China Proliferative Diabetic Retinopathy Sales Market Share by Company in 2018
Table China Proliferative Diabetic Retinopathy Sales (K Units) by Type (2014-2019)
Table China Proliferative Diabetic Retinopathy Sales Market Share by Type (2014-2019)
Figure China Proliferative Diabetic Retinopathy Sales Market Share by Type in 2018
Table China Proliferative Diabetic Retinopathy Sales (K Units) by Application (2014-2019)
Table China Proliferative Diabetic Retinopathy Sales Market Share by Application (2014-2019)
Figure China Proliferative Diabetic Retinopathy Sales Market Share by Application in 2018
Figure Japan Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate (2014-2019)
Figure Japan Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Proliferative Diabetic Retinopathy Price (USD/Unit) Trend (2014-2019)
Table Japan Proliferative Diabetic Retinopathy Sales (K Units) by Company (2014-2019)
Table Japan Proliferative Diabetic Retinopathy Sales Market Share by Company (2014-2019)
Figure Japan Proliferative Diabetic Retinopathy Sales Market Share by Company in 2018
Table Japan Proliferative Diabetic Retinopathy Sales (K Units) by Type (2014-2019)
Table Japan Proliferative Diabetic Retinopathy Sales Market Share by Type (2014-2019)
Figure Japan Proliferative Diabetic Retinopathy Sales Market Share by Type in 2018
Table Japan Proliferative Diabetic Retinopathy Sales (K Units) by Application (2014-2019)
Table Japan Proliferative Diabetic Retinopathy Sales Market Share by Application (2014-2019)
Figure Japan Proliferative Diabetic Retinopathy Sales Market Share by Application in 2018
Figure Southeast Asia Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate (2014-2019)
Figure Southeast Asia Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Proliferative Diabetic Retinopathy Price (USD/Unit) Trend (2014-2019)
Table Southeast Asia Proliferative Diabetic Retinopathy Sales (K Units) by Company (2014-2019)
Table Southeast Asia Proliferative Diabetic Retinopathy Sales Market Share by Company (2014-2019)
Figure Southeast Asia Proliferative Diabetic Retinopathy Sales Market Share by Company in 2018
Table Southeast Asia Proliferative Diabetic Retinopathy Sales (K Units) by Type (2014-2019)
Table Southeast Asia Proliferative Diabetic Retinopathy Sales Market Share by Type (2014-2019)
Figure Southeast Asia Proliferative Diabetic Retinopathy Sales Market Share by Type in 2018
Table Southeast Asia Proliferative Diabetic Retinopathy Sales (K Units) by Application (2014-2019)
Table Southeast Asia Proliferative Diabetic Retinopathy Sales Market Share by Application (2014-2019)
Figure Southeast Asia Proliferative Diabetic Retinopathy Sales Market Share by Application in 2018
Figure India Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate (2014-2019)
Figure India Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Proliferative Diabetic Retinopathy Price (USD/Unit) Trend (2014-2019)
Table India Proliferative Diabetic Retinopathy Sales (K Units) by Company (2014-2019)
Table India Proliferative Diabetic Retinopathy Sales Market Share by Company (2014-2019)
Figure India Proliferative Diabetic Retinopathy Sales Market Share by Company in 2018
Table India Proliferative Diabetic Retinopathy Sales (K Units) by Type (2014-2019)
Table India Proliferative Diabetic Retinopathy Sales Market Share by Type (2014-2019)
Figure India Proliferative Diabetic Retinopathy Sales Market Share by Type in 2018
Table India Proliferative Diabetic Retinopathy Sales (K Units) by Application (2014-2019)
Table India Proliferative Diabetic Retinopathy Sales Market Share by Application (2014-2019)
Figure India Proliferative Diabetic Retinopathy Sales Market Share by Application in 2018
Table Intas Pharmaceuticals Proliferative Diabetic Retinopathy Production Sites and Area Served
Table Intas Pharmaceuticals Proliferative Diabetic Retinopathy Specification and Application
Table Intas Pharmaceuticals Proliferative Diabetic Retinopathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Intas Pharmaceuticals Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
Figure Intas Pharmaceuticals Proliferative Diabetic Retinopathy Revenue Share in International Market (2014-2019)
Figure Intas Pharmaceuticals Proliferative Diabetic Retinopathy Main Business and Markets Served
Table Santen Pharmaceutical Proliferative Diabetic Retinopathy Production Sites and Area Served
Table Santen Pharmaceutical Proliferative Diabetic Retinopathy Specification and Application
Table Santen Pharmaceutical Proliferative Diabetic Retinopathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Santen Pharmaceutical Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
Figure Santen Pharmaceutical Proliferative Diabetic Retinopathy Revenue Share in International Market (2014-2019)
Figure Santen Pharmaceutical Proliferative Diabetic Retinopathy Main Business and Markets Served
Table Valeant Pharmaceuticals International Proliferative Diabetic Retinopathy Production Sites and Area Served
Table Valeant Pharmaceuticals International Proliferative Diabetic Retinopathy Specification and Application
Table Valeant Pharmaceuticals International Proliferative Diabetic Retinopathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Valeant Pharmaceuticals International Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
Figure Valeant Pharmaceuticals International Proliferative Diabetic Retinopathy Revenue Share in International Market (2014-2019)
Figure Valeant Pharmaceuticals International Proliferative Diabetic Retinopathy Main Business and Markets Served
Table Allergan Plc Proliferative Diabetic Retinopathy Production Sites and Area Served
Table Allergan Plc Proliferative Diabetic Retinopathy Specification and Application
Table Allergan Plc Proliferative Diabetic Retinopathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Allergan Plc Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
Figure Allergan Plc Proliferative Diabetic Retinopathy Revenue Share in International Market (2014-2019)
Figure Allergan Plc Proliferative Diabetic Retinopathy Main Business and Markets Served
Table Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Production Sites and Area Served
Table Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Specification and Application
Table Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
Figure Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Revenue Share in International Market (2014-2019)
Figure Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Main Business and Markets Served
Table Merck KGaA Proliferative Diabetic Retinopathy Production Sites and Area Served
Table Merck KGaA Proliferative Diabetic Retinopathy Specification and Application
Table Merck KGaA Proliferative Diabetic Retinopathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Merck KGaA Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
Figure Merck KGaA Proliferative Diabetic Retinopathy Revenue Share in International Market (2014-2019)
Figure Merck KGaA Proliferative Diabetic Retinopathy Main Business and Markets Served
Table Cipla Proliferative Diabetic Retinopathy Production Sites and Area Served
Table Cipla Proliferative Diabetic Retinopathy Specification and Application
Table Cipla Proliferative Diabetic Retinopathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Cipla Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
Figure Cipla Proliferative Diabetic Retinopathy Revenue Share in International Market (2014-2019)
Figure Cipla Proliferative Diabetic Retinopathy Main Business and Markets Served
Table Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Production Sites and Area Served
Table Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Specification and Application
Table Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
Figure Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Revenue Share in International Market (2014-2019)
Figure Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Main Business and Markets Served
Table Novartis Proliferative Diabetic Retinopathy Production Sites and Area Served
Table Novartis Proliferative Diabetic Retinopathy Specification and Application
Table Novartis Proliferative Diabetic Retinopathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Novartis Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
Figure Novartis Proliferative Diabetic Retinopathy Revenue Share in International Market (2014-2019)
Figure Novartis Proliferative Diabetic Retinopathy Main Business and Markets Served
Table Pfizer Proliferative Diabetic Retinopathy Production Sites and Area Served
Table Pfizer Proliferative Diabetic Retinopathy Specification and Application
Table Pfizer Proliferative Diabetic Retinopathy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Pfizer Proliferative Diabetic Retinopathy Sales Growth Rate (2014-2019)
Figure Pfizer Proliferative Diabetic Retinopathy Revenue Share in International Market (2014-2019)
Figure Pfizer Proliferative Diabetic Retinopathy Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Proliferative Diabetic Retinopathy
Figure Manufacturing Process Analysis of Proliferative Diabetic Retinopathy
Figure Proliferative Diabetic Retinopathy Industrial Chain Analysis
Table Proliferative Diabetic Retinopathy Distributors List
Table Proliferative Diabetic Retinopathy Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Proliferative Diabetic Retinopathy Price (USD/Unit) and Trend Forecast (2019-2025)
Table Global Proliferative Diabetic Retinopathy Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Proliferative Diabetic Retinopathy Sales Market Share Forecast by Regions (2019-2025)
Figure Global Proliferative Diabetic Retinopathy Sales Market Share Forecast by Regions in 2025
Table Global Proliferative Diabetic Retinopathy Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Proliferative Diabetic Retinopathy Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Proliferative Diabetic Retinopathy Revenue Market Share Forecast by Regions in 2025
Figure United States Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure United States Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Proliferative Diabetic Retinopathy Revenue and Growth Rate Forecast (2019-2025)
Figure China Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure China Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Proliferative Diabetic Retinopathy Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure India Proliferative Diabetic Retinopathy Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Proliferative Diabetic Retinopathy Sales (K Units) Forecast by Type (2019-2025)
Figure Global Proliferative Diabetic Retinopathy Sales Market Share Forecast by Type (2019-2025)
Table Global Proliferative Diabetic Retinopathy Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Proliferative Diabetic Retinopathy Revenue Market Share Forecast by Type (2019-2025)
Table Global Proliferative Diabetic Retinopathy Price (USD/Unit) Forecast by Type (2019-2025)
Table Global Proliferative Diabetic Retinopathy Sales (K Units) Forecast by Application (2019-2025)
Figure Global Proliferative Diabetic Retinopathy Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の糖尿病性網膜症治療薬市場：市場規模・現状・予測

Global Diabetic Retinopathy Drugs Market Size, Status and Forecast 2019-2025
QYR9N7094 2019年6月14日 93Pages
当資料は、糖尿病性網膜症治療薬のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、オプティナ、イルヴィアン、ベタメタゾン、オズルデックス、その他）、用途別（50〜60歳、60〜70歳、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、...

世界の糖尿病性ケトアシドーシス治療市場：市場規模・現状・予測

Global Diabetic Ketoacidosis Treatments Market Size, Status and Forecast 2019-2025
QYR9N7091 2019年6月14日 96Pages
当資料は、糖尿病性ケトアシドーシス治療のグローバル市場について調査・分析したレポートで、種類別（補液、電解液の交換、インスリン療法）、用途別（病院、外来治療センター、専門クリニック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...

世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測

Global Diabetic Macular Edema Treatment Market Size, Status and Forecast 2019-2025
QYR9N7092 2019年6月14日 95Pages
当資料は、糖尿病性黄斑浮腫の治療のグローバル市場について調査・分析したレポートで、種類別（レーザー光凝固療法、薬理学療法、ベバシズマブ、ラニビズマブ、トリアムシノロン）、用途別（病院、眼科診療所、研究機関、受託研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市...

世界の糖尿病性神経障害薬市場：市場規模・現状・予測

Global Diabetic Neuropathy Drugs Market Size, Status and Forecast 2019-2025
QYR9N7093 2019年6月14日 93Pages
当資料は、糖尿病性神経障害薬のグローバル市場について調査・分析したレポートで、種類別（カルシウムチャンネルアルファ-2デルタリガンド、SNRIとTCA、その他）、用途別（病院、ドラッグストア、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関...

世界の糖尿病性足部潰瘍治療薬市場：市場規模・現状・予測

Global Diabetic Foot Ulcer Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7090 2019年6月14日 94Pages
当資料は、糖尿病性足部潰瘍治療薬のグローバル市場について調査・分析したレポートで、種類別（事前創傷包帯、代用皮膚、陰圧創傷治療装置、成長因子）、用途別（病院、専門クリニック、介護センター、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予...

世界のラニビズマブ市場：市場規模・現状・予測

Global Ranibizumab Market Size, Status and Forecast 2019-2025
QYR9N7929 2019年6月14日 92Pages
当資料は、ラニビズマブのグローバル市場について調査・分析したレポートで、種類別（使い捨てプレフィルドシリンジ、使い捨てガラスバイアル）、用途別（wAMD、糖尿病性網膜症（DR）、糖尿病性黄斑浮腫（DME）、mCNV、RVO）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）...

世界の使い捨て眼科手術装置市場：市場規模・現状・予測

Global Single Use Ophthalmic Surgical Devices Market Size, Status and Forecast 2019-2025
QYR9N8038 2019年6月14日 98Pages
当資料は、使い捨て眼科手術装置のグローバル市場について調査・分析したレポートで、種類別（ドレープ、眼の状態管理に使用される液体、縫合糸、眼科用染料、アイシールド、その他の使い捨て器具）、用途別（糖尿病性網膜症、白内障手術、緑内障手術、屈折矯正手術、角膜手術、その他）、主要地域別（アメリカ、ヨーロッパ...

世界の黄斑浮腫治療薬市場：市場規模・現状・予測

Global Macular Edema Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7495 2019年6月14日 109Pages
当資料は、黄斑浮腫治療薬のグローバル市場について調査・分析したレポートで、種類別（レーザー治療、抗VEGF注射、抗炎症治療、硝子体手術）、用途別（嚢胞状黄斑浮腫（CME）、糖尿病性黄斑浮腫（DME））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関...

世界の網膜バイオシミラー市場：市場規模・現状・予測

Global Retinal Biosimilars Market Size, Status and Forecast 2019-2025
QYR9N7963 2019年6月14日 94Pages
当資料は、網膜バイオシミラーのグローバル市場について調査・分析したレポートで、種類別（黄斑変性症の薬、糖尿病性眼疾患治療薬、黄斑パッカー薬、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業...

世界のノシセプチン受容体市場2019

Global Nociceptin Receptor Sales Market Report 2019
QYR9N2909 2019年6月13日 106Pages
本調査レポートでは、ノシセプチン受容体の世界市場について調査・分析し、ノシセプチン受容体のメーカー別販売量、市場シェア分析、種類別販売分析（AT-403、BTRX-246040、セブラノパドール、GRT-6010、GRTTA-2210、その他）、用途別販売分析（糖尿病性神経障害性疼痛、麻薬中毒、大鬱...

世界の糖尿病性網膜症治療薬市場：市場規模・現状・予測 Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes.The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising …
世界の糖尿病性ケトアシドーシス治療市場：市場規模・現状・予測 Diabetic ketoacidosis is diagnosed by blood tests that show high levels of glucose, ketones and acid.In 2018, the global Diabetic Ketoacidosis Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report foc…
世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測 Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.Increasing prevalence of diabetes in the prime factor driving g…
世界の糖尿病性神経障害薬市場：市場規模・現状・予測 Diabetic neuropathies are nerve damaging disorders associated with diabetes mellitus. These conditions are thought to result from a diabetic microvascular injury involving small blood vessels that supply nerves (vasa nervorum) in addition to macrovascular conditions that can accumulate in diabetic n…
世界の糖尿病性足部潰瘍治療薬市場：市場規模・現状・予測 Major market players in the global diabetic foot ulcer therapeutics market are introducing innovative and expanded line products to retain their global market share. Over the last few decades, an increasing number of diabetic foot ulcer therapeutics manufacturers have been focusing on introducing br…